Teva Pharmaceutical Industries reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy. CEO Richard Francis speaks with Bloomberg's Scarlet Fu and Katie Griefeld.

Senior Fellow at Council on Foreign Relations Rebecca Patterson Talks "Too Much"
07:54

Chief Economist at New Century Advisors Claudia Sahm Talks Labor Market
08:57

NEC Director Kevin Hassett Talks US Debt
09:38